TABLE 1.
Author (year) |
Country | Design | Mode of infection |
Sample size |
Median age | Participants | Main outcome | Main finding | Ref | ||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
||||||||||||
Qualitative/ semi- struct |
Cross- section |
Cohort | Patients | Care- givers |
Providers | ||||||||
| |||||||||||||
Retention/ loss to follow-up and mortality outcomes, +/− other outcomes and +/− young people’s views | |||||||||||||
| |||||||||||||
Izzo (2017) | Italy | X | Perinatal | 24 | 18 at transition | X | Retention (not defined), CD4, viral suppression, ART | 100% retained 12m post-transition, and 76% 52 months later. 63% (75%) VL<50c/ml at transition (12 months post-transition). Median CD4 was 534 c/mm3 at transition (n=24), 626 c/mm3 1 year later (n=24), and 716c/mm3 52 months later (n=19). Proportion taking integrase inhibitors increased post-transition. | [5] | ||||
| |||||||||||||
Sainz (2017) | Spain | X | Perinatal | 209 | 18 at transition | X | Loss to follow-up (not defined), mortality, viral suppression | 14% loss to follow-up during or immediately after transition. 4 (2%) died post-transition. 86% who had VL<50c/ml pre-transition remained suppressed post-transition | [6] | ||||
| |||||||||||||
Judd (2017) | UK | X | Perinatal | 271 | 17 (last paed visit) | X | Mortality, CD4, viral suppression (two consecutive viral loads>400c/ml or one viral load >10,000 c/ml) | 7 (3%) died post-transition. CD4 declined pre-transition, and continued to decline in some groups post-transition. Viral load suppression was similar in the 12 months pre-transfer and post-transfer (53%, 48%) | [7] | ||||
| |||||||||||||
Kakkar (2016) | Canada | X | X | Perinatal | 25 | All transfer to adult care at 18. Mean 22 years at follow-up | X | Retention (≥1 clinic visit within 6 months of interview), CD4 | 76% were retained a mean of 3.6 years after transition from paediatric to adult care. Mean CD4 decreased from 524 c/mm3 at transfer to 370 one year later. Participants felt that 18 years was too young an age to transfer. | [8] | |||
| |||||||||||||
Hussen (2017) | USA | X | 15% perinatal | 72 | 25 (first adult visit) | X | Retention (≥2 visits ≥3 months apart), viral suppression | 89% (56%) retained in 1st (2nd) year after transition to adult care. Following transition, those seen sooner in adult care had higher viral suppression. | [9] | ||||
62.5% MSM | |||||||||||||
22% heterosex’l | |||||||||||||
| |||||||||||||
Ryscavage (2016) | USA | X | 38% perinatal | 50 | Perinatal 22 horizontal 25 at transition | X | Retention (≥2 visits over 12 months following linkage (1st adult care visit)) | 86% were linked to adult care, of whom 58% were retained in adult care at 12 months. Retention was higher in those with perinatal HIV (69%) vs horizontal HIV (52%). | [10] | ||||
62% horizontal | |||||||||||||
| |||||||||||||
Immunological and virological outcomes | |||||||||||||
| |||||||||||||
Weijsenfeld (2016) | Netherlands | X | 78% perinatal | 59 | 19 at transition | X | Virological, social | Proportion with viral failure increased during transition to adult care vs pre-transition paediatric care. Low education attainment and less autonomy of ART adherence predicted failure. | [11] | ||||
| |||||||||||||
Westling (2016) | Sweden | X | 91% perinatal | 34 at baseline, 29 2 years later | 19 at transition | X | Virological, ART | 2 years after transfer from paediatric to transition clinic, 90% of 29 were on ART, of which 61% took integrase inhibitors, and 92% had viral load <50c/ml | [12] | ||||
| |||||||||||||
Young people’s views | |||||||||||||
| |||||||||||||
Judd (2017) | UK | X | Perinatal | 120 | n=38 in paediatric care: 16 yrs | X | Rating of adult care vs paediatric care; readiness to self-manage care | Most rated adult care as better or no different to paediatric care for services and support offered. Those in adult care were better able to self-manage their care. | [13] | ||||
n=82 in adult care: 20 yrs | |||||||||||||
| |||||||||||||
Provider views | |||||||||||||
| |||||||||||||
Le Roux (2017) | France | X | Perinatal | 18 | N/A | X | Transition practices | Adult care providers attempted to adapt their practice to YP with perinatal HIV transferring from paediatric to adult care. Practice depended on the needs of each patient. | [14] | ||||
| |||||||||||||
Tanner (2017) | USA | X | Perinatal, horizontal | 58 | N/A | X | Transition processes, barriers and facilitators; definitions of successful transition | Providers identified components of successful transition from adolescent to adult care. Several structural, clinical and individual factors were identified as transition barriers. Collaborative process of transition from adolescent to adult clinics was recommended to facilitate uninterrupted care | [15–17] | ||||
Philbin (2017) | |||||||||||||
Philbin (2017) | |||||||||||||
| |||||||||||||
Adolescent and youth friendly services | |||||||||||||
| |||||||||||||
Griffith (2016) | USA | X | Perinatal, horizontal | 132 | 25 | X | Retention (≥6 month gap in care; ≥2 visits ≥90 days apart) at 12 months in youth-targeted care vs adult clinic | A lower proportion of those receiving youth-targeted care had a 6 month gap in care (44% vs 59%) and a higher proportion had 2 appointments ≥90 days apart (83% vs 69%). | [18] | ||||
16/54 receiving youth-targeted care were PHIV | |||||||||||||
| |||||||||||||
Lee (2016) | USA | X | 19% heterosexual, 44% MSM, 35% perinatal or transfusion-acquired | 680 | 25% 15–19 | X | Retention in care (≥2 HIV care visits ≥90 days apart within 12 months) stratified by “youth friendly” clinic factors | 85% were retained in care overall. After adjustment for demographic and clinical factors, retention was higher in clinics with youth-friendly waiting areas, evening clinic hours, and providers with adolescent health training. | [19] | ||||
75% 20–24 |